JP Morgan Chase’s Jin Medical International ZJYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13 Buy
+7
New +$16 ﹤0.01% 8027
2025
Q3
– Sell
-31
Closed -$395 – 7766
2025
Q2
$395 Sell
31
-93
-75% -$1.42K ﹤0.01% 6716
2025
Q1
$1.84K Buy
+124
New +$2.06K ﹤0.01% 6555
2024
Q2
– Sell
-1,057
Closed -$81.2K – 7794
2024
Q1
$81.2K Buy
1,057
+900
+573% +$132K ﹤0.01% 5763
2023
Q4
$38.9K Sell
157
-116
-42% -$3.93K ﹤0.01% 6073
2023
Q3
$6.39K Buy
+273
New +$3.48K ﹤0.01% 6334

Other funds holding ZJYL

JP Morgan Chase's ZJYL Position: Q3 2026 in Review

JP Morgan Chase opened a new position in Jin Medical International (ZJYL) in Q3 2026: 7 shares worth $13. The stake represents ﹤0.01% of the portfolio and ranks #8027 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in ZJYL as recently as Q2 2025.

JP Morgan Chase first reported a position in ZJYL in Q3 2023 and has held it in 6 quarters since. The position peaked at $81.2K in Q1 2024. 2 funds tracked by Wall St. Rank hold ZJYL as of Q3 2026.

  • JP Morgan Chase held 7 shares of Jin Medical International worth $13 as of Q3 2026.
  • Jin Medical International was a new JP Morgan Chase position in Q3 2026.
  • Jin Medical International made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #8027 holding.
  • JP Morgan Chase first reported a position in Jin Medical International in Q3 2023 and has held it in 6 quarters since.
  • JP Morgan Chase's Jin Medical International position peaked at $81.2K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Jin Medical International as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.